| 1 |
34605949 |
10.1007/s00277-021-04671-0 |
2022 |
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma. |
CARD11 |
| 2 |
34654055 |
10.1182/bloodadvances.2021006034 |
2022 |
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. |
CARD11 |
| 3 |
34664256 |
10.1111/bjh.17894 |
2022 |
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA. |
CARD11 |
| 4 |
34783281 |
10.1080/10428194.2021.1999444 |
2022 |
Targeting MALT1 for the treatment of diffuse large B-cell lymphoma. |
CARD11 |
| 5 |
34791836 |
10.1002/cam4.4422 |
2022 |
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. |
CARD11 |
| 6 |
34837284 |
10.1111/cas.15224 |
2022 |
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. |
CARD11 |
| 7 |
35038193 |
10.1111/his.14617 |
2022 |
Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort. |
CARD11 |
| 8 |
35158799 |
10.3390/cancers14030531 |
2022 |
CARD9 Forms an Alternative CBM Complex in Richter Syndrome. |
CARD11 |
| 9 |
35218741 |
10.1016/j.bcp.2022.114977 |
2022 |
Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases. |
CARD11 |
| 10 |
35230873 |
10.1126/scisignal.abk3083 |
2022 |
Phosphorylation of serine-893 in CARD11 suppresses the formation and activity of the CARD11-BCL10-MALT1 complex in T and B cells. |
CARD11 |
| 11 |
35240014 |
10.4143/crt.2022.017 |
2022 |
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. |
CARD11 |
| 12 |
35411950 |
10.1002/cbf.3702 |
2022 |
USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma. |
CARD11 |
| 13 |
35651609 |
10.3389/fimmu.2022.878989 |
2022 |
Hyper-IgE and Carcinoma in CADINS Disease. |
CARD11 |
| 14 |
35658124 |
10.1158/2159-8290.CD-21-1566 |
2022 |
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL. |
CARD11 |
| 15 |
35734168 |
10.3389/fimmu.2022.922471 |
2022 |
m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment. |
CARD11 |
| 16 |
35885931 |
10.3390/genes13071144 |
2022 |
Targeting a Novel G-Quadruplex in the <i>CARD11</i> Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group. |
CARD11 |
| 17 |
35928872 |
10.3389/fonc.2022.932674 |
2022 |
Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma. |
CARD11 |
| 18 |
35954378 |
10.3390/cancers14153716 |
2022 |
Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma. |
CARD11 |
| 19 |
35981904 |
10.1016/j.jaci.2022.06.023 |
2022 |
The role of the CBM complex in allergic inflammation and disease. |
CARD11 |
| 20 |
36051079 |
10.1002/jha2.428 |
2022 |
Targetable alterations in primary extranodal diffuse large B-cell lymphoma. |
CARD11 |
| 21 |
32583848 |
10.1093/neuonc/noaa145 |
2021 |
Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma. |
CARD11 |
| 22 |
33098696 |
10.1111/ejh.13540 |
2021 |
RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma. |
CARD11 |
| 23 |
33232972 |
10.1182/blood.2020005244 |
2021 |
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas. |
CARD11 |
| 24 |
33263441 |
10.1080/17474086.2021.1856652 |
2021 |
Development of molecular intervention strategies for B-cell lymphoma. |
CARD11 |
| 25 |
33399078 |
10.1016/j.esmoop.2020.100012 |
2021 |
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence. |
CARD11 |
| 26 |
33426772 |
10.1111/cas.14806 |
2021 |
Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains. |
CARD11 |
| 27 |
33479306 |
10.1038/s41598-020-80376-0 |
2021 |
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. |
CARD11 |
| 28 |
33561953 |
10.3390/cancers13040650 |
2021 |
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies. |
CARD11 |
| 29 |
33581493 |
10.1016/j.ctarc.2021.100310 |
2021 |
Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic patients. |
CARD11 |
| 30 |
33872653 |
10.1016/j.jaci.2021.04.006 |
2021 |
Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency. |
CARD11 |
| 31 |
33918793 |
10.3390/cancers13081801 |
2021 |
Clinical Applications of Genomic Alterations in ATLL: Predictive Markers and Therapeutic Targets. |
CARD11 |
| 32 |
33951889 |
10.3324/haematol.2020.271957 |
2021 |
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. |
CARD11 |
| 33 |
34177947 |
10.3389/fimmu.2021.689472 |
2021 |
Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway. |
CARD11 |
| 34 |
34203889 |
10.3390/cancers13122993 |
2021 |
Genetic Characterization and Clinical Features of <i>Helicobacter pylori</i> Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. |
CARD11 |
| 35 |
34236648 |
10.1007/978-1-0716-1669-7_20 |
2021 |
Generation and Surgical Analysis of Genetic Mouse Models to Study NF-κB-Driven Pathogenesis of Diffuse Large B Cell Lymphoma. |
CARD11 |
| 36 |
34256839 |
10.1186/s40164-021-00232-3 |
2021 |
Progress in molecular feature of smoldering mantle cell lymphoma. |
CARD11 |
| 37 |
34447369 |
10.3389/fimmu.2021.671755 |
2021 |
Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. |
CARD11 |
| 38 |
34559885 |
10.1111/cei.13662 |
2021 |
Progressive B cell depletion in human MALT1 deficiency. |
CARD11 |
| 39 |
34651869 |
10.1002/hon.2933 |
2021 |
The resistance mechanisms and treatment strategies of BTK inhibitors in B-cell lymphoma. |
CARD11 |
| 40 |
34679437 |
10.3390/diagnostics11101739 |
2021 |
Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis. |
CARD11 |
| 41 |
34722279 |
10.3389/fonc.2021.733848 |
2021 |
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma. |
CARD11 |
| 42 |
31423576 |
10.1111/bjh.16159 |
2020 |
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy. |
CARD11 |
| 43 |
31738823 |
10.1182/blood.2019002699 |
2020 |
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. |
CARD11 |
| 44 |
31883669 |
10.1016/j.pathol.2019.09.014 |
2020 |
The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma. |
CARD11 |
| 45 |
31961340 |
10.1172/JCI97040 |
2020 |
GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein. |
CARD11 |
| 46 |
31964218 |
10.1177/1078155219895079 |
2020 |
Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level. |
CARD11 |
| 47 |
32059783 |
10.1016/j.cell.2020.01.029 |
2020 |
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody. |
CARD11 |
| 48 |
32473470 |
10.1016/j.cellimm.2020.104129 |
2020 |
Gain-of-function mutations in CARD11 promote enhanced aggregation and idiosyncratic signalosome assembly. |
CARD11 |
| 49 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
CARD11 |
| 50 |
32598477 |
10.1182/bloodadvances.2019001350 |
2020 |
Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. |
CARD11 |
| 51 |
32721634 |
10.1016/j.cellimm.2020.104158 |
2020 |
Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist. |
CARD11 |
| 52 |
32770099 |
10.1038/s41598-020-70310-9 |
2020 |
Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study. |
CARD11 |
| 53 |
32779615 |
10.3960/jslrt.20019 |
2020 |
Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma. |
CARD11 |
| 54 |
33052237 |
10.7150/thno.47533 |
2020 |
Targeting BCL10 by small peptides for the treatment of B cell lymphoma. |
CARD11 |
| 55 |
33154951 |
10.3389/fonc.2020.591577 |
2020 |
Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. |
CARD11 |
| 56 |
33188997 |
10.1016/j.ctarc.2020.100235 |
2020 |
Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study. |
CARD11 |
| 57 |
33216547 |
10.1021/acs.jmedchem.0c01246 |
2020 |
Optimization of the <i>In Vivo</i> Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood. |
CARD11 |
| 58 |
29734251 |
10.1097/PAI.0000000000000585 |
2019 |
MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma. |
CARD11 |
| 59 |
30360939 |
10.1016/j.leukres.2018.10.003 |
2019 |
Immunohistochemical distinction of ABC and GCB in extranodal DLBCL is not reflected in mutation patterns. |
CARD11 |
| 60 |
31000522 |
10.1158/0008-5472.CAN-18-3438 |
2019 |
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma. |
CARD11 |
| 61 |
31060714 |
10.1016/j.jaci.2019.03.009 |
2019 |
Germline CBM-opathies: From immunodeficiency to atopy. |
CARD11 |
| 62 |
31132650 |
10.1016/j.anndiagpath.2019.05.004 |
2019 |
TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant. |
CARD11 |
| 63 |
31150604 |
10.1016/j.jid.2019.05.008 |
2019 |
Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type. |
CARD11 |
| 64 |
31391255 |
10.1074/jbc.RA119.009551 |
2019 |
Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling. |
CARD11 |
| 65 |
31554683 |
10.1128/JVI.01499-19 |
2019 |
Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons. |
CARD11 |
| 66 |
31644910 |
10.1016/j.celrep.2019.09.040 |
2019 |
MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells. |
CARD11 |
| 67 |
31662757 |
10.1155/2019/9832956 |
2019 |
MicroRNA-181a Inhibits Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Progression by Repressing <i>CARD11</i>. |
CARD11 |
| 68 |
29074501 |
10.1182/blood-2017-09-804641 |
2018 |
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial. |
CARD11 |
| 69 |
29382759 |
10.1073/pnas.1721967115 |
2018 |
Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome. |
CARD11 |
| 70 |
29587428 |
10.3390/biomedicines6020038 |
2018 |
NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy. |
CARD11 |
| 71 |
29891112 |
10.1016/j.critrevonc.2018.05.010 |
2018 |
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. |
CARD11 |
| 72 |
29899297 |
10.3390/ijms19061758 |
2018 |
Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy. |
CARD11 |
| 73 |
29925955 |
10.1038/s41586-018-0290-0 |
2018 |
A multiprotein supercomplex controlling oncogenic signalling in lymphoma. |
CARD11 |
| 74 |
30022982 |
10.3389/fimmu.2018.01539 |
2018 |
BCL10 - Bridging CARDs to Immune Activation. |
CARD11 |
| 75 |
30032036 |
10.1016/j.neo.2018.07.001 |
2018 |
Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma. |
CARD11 |
| 76 |
30087457 |
10.1038/s41374-018-0096-6 |
2018 |
Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues. |
CARD11 |
| 77 |
30127060 |
10.1084/jem.20180230 |
2018 |
Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation. |
CARD11 |
| 78 |
30279415 |
10.1038/s41467-018-06573-8 |
2018 |
Molecular architecture and regulation of BCL10-MALT1 filaments. |
CARD11 |
| 79 |
30283440 |
10.3389/fimmu.2018.02078 |
2018 |
The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex. |
CARD11 |
| 80 |
30283447 |
10.3389/fimmu.2018.02105 |
2018 |
Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease. |
CARD11 |
| 81 |
30336982 |
10.1016/j.bbrc.2018.10.029 |
2018 |
MALT1 activation by TRAF6 needs neither BCL10 nor CARD11. |
CARD11 |
| 82 |
30402490 |
10.1155/2018/6728128 |
2018 |
Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion. |
CARD11 |
| 83 |
30474008 |
10.3389/fonc.2018.00498 |
2018 |
Post-translational Modifications of the CARMA1-BCL10-MALT1 Complex in Lymphocytes and Activated B-Cell Like Subtype of Diffuse Large B-Cell Lymphoma. |
CARD11 |
| 84 |
26354285 |
10.1002/hon.2251 |
2017 |
Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma. |
CARD11 |
| 85 |
27297871 |
10.1111/his.13015 |
2017 |
Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications. |
CARD11 |
| 86 |
27864294 |
10.1182/blood-2016-05-718775 |
2017 |
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma. |
CARD11 |
| 87 |
27915469 |
10.1002/cncr.30404 |
2017 |
MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma. |
CARD11 |
| 88 |
28073005 |
10.1016/j.ccell.2016.12.003 |
2017 |
Simultaneous Inhibition of PI3Kδ and PI3Kα Induces ABC-DLBCL Regression by Blocking BCR-Dependent and -Independent Activation of NF-κB and AKT. |
CARD11 |
| 89 |
28153771 |
10.1016/j.ebiom.2017.01.027 |
2017 |
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study. |
CARD11 |
| 90 |
28319526 |
10.1097/PAS.0000000000000836 |
2017 |
Anaplastic Variant of Diffuse Large B-cell Lymphoma Displays Intricate Genetic Alterations and Distinct Biological Features. |
CARD11 |
| 91 |
28619981 |
10.1158/2159-8290.CD-17-0613 |
2017 |
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma. |
CARD11 |
| 92 |
28627735 |
10.1111/cas.13303 |
2017 |
Genetic alterations in adult T-cell leukemia/lymphoma. |
CARD11 |
| 93 |
28664939 |
10.1038/modpathol.2017.58 |
2017 |
Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms. |
CARD11 |
| 94 |
28682481 |
10.1002/path.4933 |
2017 |
Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma. |
CARD11 |
| 95 |
28993276 |
10.1016/j.humpath.2017.09.013 |
2017 |
A distinctive subgroup of oral EBV+ B-cell neoplasm with polymorphous features is potentially identical to EBV+ mucocutaneous ulcer. |
CARD11 |
| 96 |
29222279 |
10.1182/asheducation-2017.1.358 |
2017 |
Follicular lymphoma: are we ready for a risk-adapted approach? |
CARD11 |
| 97 |
29245897 |
10.18632/oncotarget.18502 |
2017 |
Comparative analysis of primary <i>versus</i> relapse/refractory DLBCL identifies shifts in mutation spectrum. |
CARD11 |
| 98 |
29262531 |
10.18632/oncotarget.21986 |
2017 |
Mutational profile of primary breast diffuse large B-cell lymphoma. |
CARD11 |
| 99 |
29340061 |
10.18632/oncotarget.22799 |
2017 |
Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets. |
CARD11 |
| 100 |
26608593 |
10.1002/gcc.22328 |
2016 |
Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma. |
CARD11 |
Datasets
Models
